{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2021,"dc_identifier":"nl.oorg10123.2j.2021.809","dc_publisher":"oorg10123","dc_publisher_name":"Rijksinstituut voor Volksgezondheid en Milieu","dc_source":"https://www.rivm.nl/publicaties/acceptability-feasibility-and-likelihood-of-stakeholders-implementing-novel-bpal","dc_title":"Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients. | RIVM","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_extraMetadata":{},"foi_files":[],"foi_isWoo":"Ja","foi_page_title":"Onderzoek Rijksinstituut voor Volksgezondheid en Milieu","foi_publishedDate":"2021-07-27","foi_retrievedDate":"2024-12-01","tooiwl_type":"c_fdaee95e"},"resource":"nl.oorg10123.2j.2021.809"}